Concomitant treatment of combined cardiac diseases during TAVI is an appealing option for high-risk patients, with the choice of staged versus single-session depending on individual patient factors.
Answers are grounded in this paper and cite their sources.
Supports individualized concomitant procedures during TAVI in high-risk patients; leaves open optimal staging pending prospective trials.
In high-risk patients with aortic stenosis and associated cardiac comorbidities (such as coronary artery disease, atrial fibrillation or combined valve disease), transcatheter interventions offer a unique opportunity to mitigate these individuals' cardiovascular risk, either by staging the interventions, or by performing simultaneous procedures in a single session. The decision on which approach (staged vs. single session) to choose for an individual patient depends on clinical, anatomical and patient-related factors. While a staged approach may represent a preferable strategy in selected patients, concomitant treatment of combined cardiac diseases represents an appealing option in a majority of patients.
No takes yet. Share an insight, caveat, or question.
Taramasso et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: